Webinar on Clinical Medicine | Prediction of Preterm Birth in High Risk Pregnancies
Webinar on Clinical Medicine | Prediction of Preterm Birth in High Risk Pregnancies
Part of the Webinars on Clinical Medicine series
Prediction, PTB, clinical, Medicine
Webinar Information
4th Webinar of Journal of Clinical Medicine - an Open Access Journal
Prediction of Preterm Birth in High Risk Pregnancies
Preterm birth (PTB) remains one of the biggest challenges in contemporary obstetrics as it is associated with an increased risk of mortality as well as short- and long-term morbidity of the offspring. Many risk factors for PTB were identified, including multiple gestation, placental insufficiency, cervical pathology and uterine factors, among others. As a result, many women are currently classified as at high risk for PTB. Accurate prediction of PTB is crucial as it can assist in selecting the optimal prevention measurements and counseling regarding the suitable antepartum follow up and the need for potential transfer to the appropriate facility in case of very high risk of PTB.
With a distinguished panel of leaders in this field, Professors Liran Hiersch, John Kingdom, Nathan Fox, Tal Biron-Shental and Ido Solt, this webinar will address aspects and perspectives on the prediction of PTB in various clinical scenarios.
Dr. Liran Hiersch
Date: 6th December 2020
Time: 3.00 pm CET | 9.00am EST
Chair: Dr. Liran Hiersch
Webinar ID: 862 1088 3441
Webinar secretariat: jcm.webinar@mdpi.com
The following experts will present and speak:
|
Dr. Liran Hiersch |
Dr. Liran Hiersch is a Maternal-Fetal Medicine specialist and a staff physician at Lis Hospital for Women, Tel Aviv Medical Center, Israel. Dr. Hiersch graduated from the Sackler Faculty of Medicine, Tel Aviv University, Israel and completed his residency at the Department of Obstetrics and Gynecology at Tel Aviv Medical Center. Subsequently, he perused a fellowship in Advanced Obstetrics at Sunnybrook Health Sciences Centre as well as in Maternal-Fetal Medicine at Mount Sinai Hospital, both in Toronto, Ontario, Canada. Dr. Hiersch has co-authored over 100 original research papers, as well as 10 book chapters and reviews, and his research has been presented in numerous national and international conferences. His main fields of interest include twin pregnancies, fetal growth and preterm birth. |
|
Dr. Nathan Fox |
Dr. Nathan Fox is a board-certified specialist in Maternal Fetal Medicine. He completed medical school and residency in Obstetrics and Gynecology at Mount Sinai School of Medicine and his fellowship in Maternal Fetal Medicine at Weill Cornell Medical College. He is currently a Clinical Professor in the Department of Obstetrics, Gynecology, and Reproductive Science at the Icahn School of Medicine at Mount Sinai in New York City. Dr. Fox is a partner at Maternal Fetal Medicine Associates and Carnegie Imaging for Women, also in New York City. He is also actively involved in research and has authored over 100 peer-reviewed publications. Dr. Fox is on the editorial board of Obstetrics & Gynecology and has served on the Board of Directors for the Society for Maternal Fetal Medicine Board. Dr. Fox has won several teaching awards for resident and medical student education and serves as a research mentor and teacher for students in high school, college, medical school, and residency. He is also the creator and host of the “Healthful Woman” podcast. |
|
Prof. Tal Biron-Shental |
Tal Biron graduated from medical school at the Technion University (Haifa, Israel) and completed her residency in obstetrics and gynecology at Meir Medical Center, Kfar Saba, Affiliated with Tel Aviv University. She completed her clinical and research fellowship in maternal fetal medicine at Washington University and Barnes Jewish Hospital (St. Louis, Missouri, USA). Currently, she is the Vice of the chairman of OBYN department and the Director of the Maternal-Fetal Medicine ward at Meir Medical Center. She is the director of the residency program in Obstetrics and Gynecology at Meir Medical Center. She is a Proffesor at Tel Aviv University. Her research interests are placental biology and telomere homeostasis in pregnancy related complications, especially intra-uterine growth restriction and preeclampsia. She has contributed to decades of peer-reviewed articles. She is a member of several professional committees of OBGYN including the Israeli committee that writes the clinical guidelines in maternal-fetal medicine as well as the board examinations. |
|
Dr. John Kingdom |
John is a Clinician-Scientist and High-Risk Obstetrician in the Maternal-Fetal Medicine Division with a clinical and research focus on the full range of medical and surgical complications associated with abnormal placentation. His work centers on the Placenta Program, working with his colleagues Dr. Rory Windrim and Dr. Sebastian Hobson. His research focuses on improving clinical outcomes in women at risk of “placental insufficiency”, accurate screening, detection and avoidance of severe preeclampsia, advanced placental and Doppler imaging methods in FGR pregnancies, the non-anticoagulant actions of heparin in-vitro and in-vivo and in the diagnosis and management of invasive placentation. |
|
Dr. Ido Solt |
Dr. Ido Solt is the director of the division of Maternal-Fetal Medicine of Rambam Health Care campus, the largest tertiary center in north Israel. He serves as a Clinical Assistant Professor in the Rappaport Faculty of Medicine, Technion, Haifa, Israel. Dr. Solt pursued a fellowship in Maternal-Fetal Medicine at Cedars Sinai Medical Center, Los Angeles, USA. He is an elected member of the Board of the Israel Maternal-Fetal Medicine Society. He is an active member of the Israel Ministry of Health National Councils for Women's Health and for Community Health. |
Program
| Speakers/Presentations | Time CET |
Time EST |
|
Liran Hiersch Welcome and Introduction of the Webinar |
3.00pm | 9.00am |
|
John Kingdom Placenta Growth Factor: predicting placenta-mediated preterm delivery |
3.10pm | 9.10am |
|
Nathan Fox Prediction and Prevention of Preterm Birth in Twins |
3.35pm | 9.35am |
|
Tal Biron-Shental The correlation between telomere homeostasis and gestational length |
4.00pm | 10.00am |
|
Ido Solt Is the vaginal microbiome a predictor of preterm birth? |
4.25pm | 10.25am |
|
Q&A and conclusions |
4.50pm | 10.50am |
Webinar Content
The fourth webinar organised by MDPI and the Journal of Clinical Medicine was held on 6 December 2020 and chaired by Dr. Liran Hiersch from Tel Aviv Medical Center.
The first presenter of the webinar was Dr. John Kingdom from University of Toronto. He spoke about the Placenta Growth Factor and predicting the placenta-mediated preterm delivery. Dr. Nathan Fox, from Mount Sinai Hospital, was the second speaker and discussed the prediction and prevention of preterm birth in twins.
Prof. Dr. Tal Biron-Shental from Meir Medical Center gave the third presentation on the correlation between telomere homeostasis and gestational length. The fourth and final presentation was given by Prof. Dr. Ido Solt from Rappaport Faculty of Medicine and discussed whether the vaginal microbiome is a predictor of preterm birth.
The talks were followed by a Q&A session where the speakers answered the attendees’ questions. The webinar was offered via Zoom and required registration to attend. The full recording can be found below. In order to stay updated on the next webinars on JCM, be sure to sign up for our newsletter by clicking on “Subscribe” at the top of the page.
Relevant Special Issues
Advances in Preterm Delivery
Guest Editor: Prof. Dr. Eyal Sheiner
Deadline for manuscript submissions: 31 May 2021.
Improving Perinatal Outcomes in Twin and Multiple Pregnancy
Guest Editors: Prof. Liesbeth Lewi, Prof. Dr. Enrico Lopriore, Prof. Asma Khalil
Deadline for manuscript submissions: 31 December 2020.
Management of Complications during Pregnancy
Guest Editor: Dr. Ramesha Papanna
Deadline for manuscript submissions: 30 April 2021.
Sponsors and Partners
Organizers
